UOC
MDT icon

UBS O'Connor’s Medtronic MDT Stock Holding History

UBS O'Connor’s Portfolio MDT Stock Details MDT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-16,702
Closed -$1.46M – 601
2024
Q1 		$1.46M Sell
16,702
-5,626
-25% -$480K 0.04% 235
2023
Q4 		$1.84M Sell
22,328
-37,468
-63% -$2.86M 0.06% 184
2023
Q3 		$4.69M Buy
59,796
+15,000
+33% +$1.26M 0.08% 131
2023
Q2 		$3.95M Buy
44,796
+19,796
+79% +$1.7M 0.08% 150
2023
Q1 		$2.02M Buy
+25,000
New +$2.04M 0.05% 311

Other funds holding MDT

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

UBS O'Connor's MDT Position: Q2 2024 in Review

UBS O'Connor sold out of Medtronic (MDT) in Q2 2024, closing a stake of 16,702 shares — an estimated $1.46M sold.

UBS O'Connor first reported a position in MDT in Q1 2023 and held it in 5 quarters. The position peaked at $4.69M in Q3 2023. 2,023 funds tracked by Wall St. Rank hold MDT as of Q2 2024.

  • UBS O'Connor reported no remaining Medtronic position as of Q2 2024 after selling out during the quarter.
  • UBS O'Connor sold 16,702 Medtronic shares in Q2 2024, an estimated $1.46M.
  • UBS O'Connor first reported a position in Medtronic in Q1 2023 and held it in 5 quarters.
  • UBS O'Connor's Medtronic position peaked at $4.69M in Q3 2023.
  • 2,023 funds tracked by Wall St. Rank held Medtronic as of Q2 2024.

Based on UBS O'Connor's 13F filing for Q2 2024, filed 14 Aug 2024.